FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: We devised a cellular assay to address this clinical finding by overexpressing double mutated Flt3-ITDY591F/Y919F in chronic myeloid leukemia cell line K562 to study Mk differentiation in the presence of small molecule inhibitors.